Ratings by Barrington Research (Mike Petusky)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/5/2026 | LeMaitre Vascular | LMAT | Downgrade | Market Perform (Outperform) |
105.78 (81.08) |
-23.35% | Details | |
| 8/6/2025 | LeMaitre Vascular | LMAT | Upgrade | Outperform (Market Perform) |
85.60 (105.78) |
23.57% | Details | |
| 2/28/2025 | LeMaitre Vascular | LMAT | Downgrade | Market Perform (Outperform) |
99.91 (85.60) |
-14.32% | Details | |
| 5/3/2023 | LeMaitre Vascular | LMAT | Upgrade | Outperform (Market Perform) |
54.75 (81.08) |
48.09% | Details | |
| 6/9/2021 | Fortress Value Acquisition Corp II | FAII | New Coverage | Outperform (N/A) |
10.02 (10.28) |
2.59% | Details |
